
TY  - JOUR
AU  - Ward, Peter A.
AU  - Gao, Hongwei
TI  - Sepsis, complement and the dysregulated inflammatory response
JO  - Journal of Cellular and Molecular Medicine
VL  - 13
IS  - 10
SN  - 1582-1838
UR  - https://doi.org/10.1111/j.1582-4934.2009.00893.x
DO  - doi:10.1111/j.1582-4934.2009.00893.x
SP  - 4154
EP  - 4160
KW  - sepsis
KW  - complement
KW  - C5a
KW  - C5a receptors
KW  - apoptosis
PY  - 2009
AB  - Abstract ?? Introduction -? Models of sepsis -? Evidence for complement activation in sepsis -? Protective effects of C5a generated in limited amounts -? Sepsis-induced changes in signalling cascades -? Divergent effects on phagocytic cells during sepsis -? Harmful effects of C5a and C5a receptors in experimental sepsis ?? Future directions Sepsis in human beings is a major problem involving many individuals and with a high death rate. Except for a single drug (recombinant activated protein C) that has been approved for treatment of septic patients, supportive measures represent the main clinical approach. There are many models of experimental sepsis, mostly in rodents. A commonly used model is cecal ligation and puncture (CLP). In this model, robust activation of complement occurs together with up-regulation of C5a receptors (C5aR, C5L2) in a variety of different organs (lungs, kidneys, liver, heart). In septic human beings there is abundant evidence for complement activation. Interception of C5a or its receptors in the CLP model greatly improves survival in septic rodents. There is compelling evidence that CLP causes an intense pro-inflammatory state and that C5a interaction with its receptors can be linked to apoptosis of the lymphoid system and cells of the adrenal medulla, loss of innate immune functions of blood neutrophils, consumptive coagulopathy and cardiac dysfunction. These findings may have implications for therapeutic interventions in human beings with sepsis.
ER  - 

TY  - JOUR
TI  - Supplement Article
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 185
IS  - S1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.15854
DO  - doi:10.1111/bjh.15854
SP  - 3
EP  - 202
PY  - 2019
ER  - 

TY  - JOUR
TI  - Program: First joint meeting of the American society for bone and mineral research and the international conferences on calcium regulating hormones
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 4
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650040702
DO  - doi:10.1002/jbmr.5650040702
SP  - 1
EP  - 419
PY  - 1989
ER  - 

TY  - JOUR
AU  - Sunderkötter, Cord
AU  - Becker, Karsten
AU  - Eckmann, Christian
AU  - Graninger, Wolfgang
AU  - Kujath, Peter
AU  - Schöfer, Helmut
TI  - S2k-Leitlinie Haut- und WeichgewebeinfektionenAuszug aus „Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen – Update 2018“
JO  - JDDG: Journal der Deutschen Dermatologischen Gesellschaft
JA  - JDDG: Journal der Deutschen Dermatologischen Gesellschaft
VL  - 17
IS  - 3
SN  - 1610-0379
UR  - https://doi.org/10.1111/ddg.13790_g
DO  - doi:10.1111/ddg.13790_g
SP  - 345
EP  - 371
PY  - 2019
AB  - Zusammenfassung Diese erste deutschsprachige S2k-Leitlinie zu bakteriellen Haut- und Weichgewebeinfektionen ist im Rahmen der ?Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen? unter Federführung der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. entstanden und wird in wichtigen Auszügen hier wiedergegeben. Voraussetzung für gut kalkulierte Antibiotikatherapien ist eine genaue diagno?stische Zuordnung. So wird das Erysipel definiert als nichteitrige Infektion als deren Erreger ?-?hämolysierende Streptokokken gelten, und das klinisch diagnostiziert wird aufgrund eines hellroten Erythems und initial auftretenden Fiebers oder Fröstelns. Therapie der Wahl ist Penicillin. Begrenzte Phlegmonen dagegen werden meist durch Staphylococcus (S.) aureus verursacht, gehen häufig von Wunden aus, zeigen lividrote Erytheme und sind initial meist nicht von Fieber begleitet. Die Behandlung erfolgt mit einem Cephalosporin der Gruppe 1 oder 2 oder Flucloxacillin (parenteral). Schwere Phlegmonen sind eitrige, teilweise nekrotische, im Gewebe sich ausbreitende und bis an die Faszie reichende Infektionen, welche neben der Antibiotikabehandlung zusätzlich einer chirurgischen Versorgung bedürfen. Sie erfüllen oft auch die Kriterien für komplizierte Weichgewebeinfektionen, wie sie von der Food and Drug Administration für klinische Studien definiert worden sind (u. a. Komorbiditäten wie schlecht eingestellter Diabetes mellitus, periphere arterielle Verschlusskrankheit, Neutropenie). Hierfür werden Antibiotika empfohlen, die neben S. aureus auch anaerobe Bakterien und/oder gramnegative Bakterien erfassen. Die sogenannten nekrotisierenden Weichgewebeinfektionen sind eigenständige, rasch progrediente, akut lebensbedrohliche Infektionen infolge besonderer bakterieller Toxine, die zu ischämischen Nekrosen und Schock führen und ein schnelles radikales chirurgisches Débridement sowie entsprechende Anitbiotika erfordern. Abszesse müssen in erster Linie gut drainiert werden und erfordern nur unter bestimmten Umständen zusätzlich Antibiotika (Lokalisation im Gesicht, Hand- oder Genitoanalbereich, schwieriger Drainage etc.). Die Leitlinie enthält zusätzlich Konsensus-basierte Empfehlungen für höhere als in Studien geprüfte oder üblicherweise verabreichte Dosierungen. Ziel ist eine rationale Antibiotikatherapie, die wirksam und verträglich ist und keinen unnötigen Selektionsdruck in Richtung (multi-)resistenter Erreger ausübt.
ER  - 

TY  - JOUR
TI  - Poster Presentation – Tuberculosis
JO  - Respirology
JA  - Respirology
VL  - 19
IS  - S3
SN  - 1323-7799
UR  - https://doi.org/10.1111/resp.12417_17
DO  - doi:10.1111/resp.12417_17
SP  - 235
EP  - 253
PY  - 2014
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Clinical Microbiology and Infection
VL  - 13
IS  - s1
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2007.01732.x
DO  - doi:10.1111/j.1469-0691.2007.01732.x
SP  - S1
EP  - S108
PY  - 2007
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2009 Poster presentations
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 96
IS  - S4
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.6641
DO  - doi:10.1002/bjs.6641
SP  - 82
EP  - 182
PY  - 2009
AB  - Abstract The Annual Scientific Meeting of the Association of Surgeons of Great Britain and Ireland takes place this year at the Scottish Exhibition and Conference Centre, Glasgow, UK (13th?15th May 2009), under the presidency of Professor Michael Horrocks. To view the abstracts from this meeting, please click the pdf link on this page. Copyright ? 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - 13th European Congress of Clinical Microbiology and Infectious Diseases
JO  - Clinical Microbiology and Infection
VL  - 9
IS  - s1
SN  - 1198-743X
UR  - https://doi.org/10.1046/j.1469-0691.9.s1.83.x
DO  - doi:10.1046/j.1469-0691.9.s1.83.x
SP  - 1
EP  - 422
PY  - 2003
ER  - 

TY  - JOUR
TI  - The International Liver Transplantation Society: 14th Annual International Congress, July 9–12, 2008, Paris, France
JO  - Liver Transplantation
JA  - Liver Transpl
VL  - 14
IS  - S1
SN  - 1527-6465
UR  - https://doi.org/10.1002/lt.21569
DO  - doi:10.1002/lt.21569
SP  - S1
EP  - S269
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts accepted for publication only
JO  - Clinical Microbiology and Infection
VL  - 14
IS  - s7
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2008.02008.x
DO  - doi:10.1111/j.1469-0691.2008.02008.x
SP  - S667
EP  - S759
PY  - 2008
ER  - 

TY  - JOUR
TI  - SIOP 2016 Scientific Programme+Index
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 63
IS  - S3
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.26233
DO  - doi:10.1002/pbc.26233
SP  - S5
EP  - S321
PY  - 2016
ER  - 

TY  - JOUR
AU  - Peters, Edgar J.
C8  - DMRR-15-PER-226.R1
TI  - Pitfalls in diagnosing diabetic foot infections
JO  - Diabetes/Metabolism Research and Reviews
JA  - Diabetes Metab Res Rev
VL  - 32
IS  - S1
SN  - 1520-7552
UR  - https://doi.org/10.1002/dmrr.2736
DO  - doi:10.1002/dmrr.2736
SP  - 254
EP  - 260
KW  - diabetes mellitus
KW  - infection
KW  - foot
KW  - diagnosis
KW  - radiology
KW  - microbiology
PY  - 2016
AB  - Abstract Although the diagnosis of a diabetic foot infection is made based on clinical symptoms and signs, we also use blood laboratory, microbiological and radiological studies to make treatment decisions. All of these diagnostic studies have pitfalls that can lead to a delay in diagnosis. Such delays will likely lead to further tissue damage and to a higher chance of amputation. One of these pitfalls is that some clinicians rely on microbiological, rather than clinical data, to diagnose infection. Though subjective by nature, clinical signs predict outcome of foot infections accurately. Another pitfall is that microbiological data can be misleading. All wounds harbour microorganisms; therefore, a positive wound culture does not mean that a wound is infected. Furthermore, the outcome of cultures of wound swabs does not correlate well with culture results of tissue biopsies. Therapy guidance by wound swab will likely lead to overtreatment of non-pathogenic organisms. Genotyping might have a role in identifying previously unrecognized (combinations of) pathogens in diabetic foot infection, bacteria in sessile phenotype and non-culturable pathogens, e.g. in cases where antibiotics have already been administered. One more pitfall is that the diagnosis of osteomyelitis remains difficult. Although the result of percutaneous bone biopsy is the reference standard for osteomyelitis, some other diagnostic modalities can aid in the diagnosis. A combination of several of these diagnostic tests is probably a good strategy to achieve a higher diagnostic accuracy. Relying on a single test will likely lead to misidentification of patients with osteomyelitis with associated overtreatment and undertreatment. Copyright ? 2016 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - 2009 Society for Academic Emergency Medicine (SAEM) Annual Meeting Abstracts
JO  - Academic Emergency Medicine
VL  - 16
IS  - s1
SN  - 1069-6563
UR  - https://doi.org/10.1111/j.1553-2712.2009.00391.x
DO  - doi:10.1111/j.1553-2712.2009.00391.x
SP  - S5
EP  - S273
PY  - 2009
ER  - 

TY  - JOUR
TI  - 2016 ACR/ARHP Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatology
JA  - Arthritis & Rheumatology
VL  - 68
IS  - S10
SN  - 2326-5191
UR  - https://doi.org/10.1002/art.39977
DO  - doi:10.1002/art.39977
SP  - 1
EP  - 4550
PY  - 2016
AB  - For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
TI  - Abstracts accepted for publication only
JO  - Clinical Microbiology and Infection
VL  - 18
IS  - s3
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2012.03803.x
DO  - doi:10.1111/j.1469-0691.2012.03803.x
SP  - 716
EP  - 844
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Urology
JA  - Int. J. Urol.
VL  - 24
IS  - S1
SN  - 0919-8172
UR  - https://doi.org/10.1111/iju.13413
DO  - doi:10.1111/iju.13413
SP  - 4
EP  - 149
PY  - 2017
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of Thrombosis and Haemostasis
VL  - 7
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2009.03473_2.x
DO  - doi:10.1111/j.1538-7836.2009.03473_2.x
SP  - 317
EP  - 1168
PY  - 2009
ER  - 

TY  - JOUR
TI  - 2017 ACR/ARHP Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatology
JA  - Arthritis & Rheumatology
VL  - 69
IS  - S10
SN  - 2326-5191
UR  - https://doi.org/10.1002/art.40321
DO  - doi:10.1002/art.40321
SP  - 1
EP  - 4481
PY  - 2017
AB  - Abstract For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Clinical Microbiology and Infection
VL  - 14
IS  - s7
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2008.02006.x
DO  - doi:10.1111/j.1469-0691.2008.02006.x
SP  - S1
EP  - S119
PY  - 2008
ER  - 

TY  - JOUR
AU  - Emura, Iwao
AU  - Usuda, Hiroyuki
TI  - Appearance of large scavenger receptor A-positive cells and increased small scavenger receptor A positive cells in peripheral blood is associated with mortality in systemic inflammatory response syndrome and multiple organ dysfunction syndrome
JO  - Pathology International
VL  - 61
IS  - 1
SN  - 1320-5463
UR  - https://doi.org/10.1111/j.1440-1827.2010.02607.x
DO  - doi:10.1111/j.1440-1827.2010.02607.x
SP  - 7
EP  - 12
KW  - multiple organ dysfunction syndrome
KW  - peripheral blood
KW  - prognosis
KW  - scavenger receptor A-positive cells
KW  - systemic inflammatory response syndrome
PY  - 2011
AB  - We investigated the association of scavenger receptor A-positive (SRA+) cells in peripheral blood (PB) with mortality in subjects with systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). A total of 467 subjects with SIRS (62 of 467 satisfied the diagnostic criteria of MODS) were prospectively examined. The subjects were classified into three groups according to the SRA index (number of small SRA+ cells in 10 high power field, normal upper limit <30) and the appearance of large SRA+ cells as follows: group A, large SRA+ cells were not detected; group B, large SRA+ cells were detected but SRA index did not exceed 30; group C, the two factors (appearance of large SRA+ cells and SRA index >30) coincided. The duration from the diagnosis of SIRS to death in groups A and B was significantly shorter than in group C. The mortality rate in group C was significantly higher than in groups A and B. Kaplan-Meier curves of group C showed significantly worse survival than groups A and B. These results indicate that the coincidence of two factors (appearance of large SRA+ cells and SRA index >30) may be useful to predict the outcome in patients with SIRS or MODS.
ER  - 
